Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and EyeBio, a wholly-owned subsidiary of Merck & Co., Inc., Rahway, N.J., USA, today announced the initiation of the Phase 2b/3 ...

It is hard to get excited after looking at Merck's (NYSE:MRK) recent performance, when its stock has declined 5.6% over the past three months. But if you pay close attention, you might find that ...

Investors with a lot of money to spend have taken a bearish stance on Merck & Co (NYSE:MRK). And retail traders should know. We noticed this today when the positions showed up on publicly ...

Merck Foundation (www.Merck-Foundation.com), the philanthropic arm of Merck KGaA Germany released the Thirteenth Episode of their first-ever TV program – ‘Our Africa by Merck Foundation’ on their ...

Two dogs belonging to a veterinary nurse killed 15 sheep after being allowed to roam free, a court heard. The Spanish greyhound and lurcher, named Pacho and Beans, were on the loose for three and ...

A Merck & Co. effort to move its PD-1 behemoth Keytruda into early treatment of lung cancer has reached a dead end, along with another bid to expand into a type of early-stage skin cancer.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Robert M. Davis, chairman and chief executive officer, and Dr. Dean Y. Li, executive vice president ...

Merck Foundation (www.Merck-Foundation.com), the philanthropic arm of Merck KGaA Germany released the Twelfth Episode of their first-ever TV program – ‘Our Africa by Merck Foundation’ on their social ...

At the School of Veterinary Medicine, we aim to inspire and educate veterinary professionals who will advance veterinary medicine to meet the needs of a changing world. We’re home to world-class ...

This, coupled with stricter emissions regulations, has meant the manual transmission is disappearing at an alarming rate. For enthusiasts who love the feel and control that only a stick shift can ...

Merck’s stock started declining after the company announced second-quarter results on Jul 25. Though the company beat earnings and sales estimates and also slightly raised the full-year guidance ...

Merck has optioned in on one Kelun Biotech antibody-drug conjugate but returned another. A few U.S. lawmakers have asked the FDA to examine clinical trials involving sites at Chinese military ...